< Back to scientific publications

Magazine 11.26

Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study.

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Cerulli Irelli E, Chiesa V, Dainese F, De Maria G, Didato G, Di Gennaro G, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAracetam add-on First Italian‚oRk Study (BRIVAFIRST) Group.

Date: 2022

Scope of interest: Epilepsy




You may also be interested in:

Magazine 2,912

Development and Validation of the HOPE Prognostic Index on 24-Month Posthospital Mortality and Rehospitalization: Italian National Research Center on Aging (INRCA)

Authors: Abbatecola AM, Spazzafumo L, Corsonello A, Sirolla C, Bustacchini S, Guffanti E.

Date: 2011

Scope of interest: ageing, geriatrics


Read details
Magazine 18.29

Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects.

Authors: Morano A, Fanella M, Albini M, Cifelli P, Palma E, Giallonardo AT, Di Bonaventura C.

Date: 2020

Scope of interest: Epilepsy


Read details
Magazine 3.7

Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome.

Authors: Bucci L et al

Date: 16 Feb 2023

Scope of interest: hepatological


Read details